Continue to practice your decision-making when intensifying treatment beyond triple therapy. Featuring local commentary from France, Spain and Italy.
A comprehensive overview of GLP-1 receptor agonists, including mechanism of action, multifactorial effects and how to predict response to their use in type 2 diabetes.
A summary of guideline recommendations in the use of GLP-1 analogues, including how to help patients manage gastrointestinal side effects.
A comprehensive summary of relevant data across GLP-1RAs, SGLT2 inhibitors and DPP-4 inhibitors, complete with guidance on how to select between these.
A review of data surrounding once-weekly GLP-1 receptor agonists, including clinical trial data and how these apply to the real world.
A summary of formulations, mechanisms of action and clinical trial data associated with alternative approaches to GLP-1 agonism. This includes oral semaglutide, implantable exenatide, and dual agonists (e.g. tirzepatide)